CoChat

mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership

Cayo, Angel, Segovia, Raúl, Venturini, Whitney, Moore-Carrasco, Rodrigo, Valenzuela, Claudio, Brown, Nelson · 2021 · International Journal of Molecular Sciences
Cited by 93

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Abstract

Cellular senescence is a form of proliferative arrest triggered in response to a wide variety of stimuli and characterized by unique changes in cell morphology and function. Although unable to divide, senescent cells remain metabolically active and acquire the ability to produce and secrete bioactive molecules, some of which have recognized pro-inflammatory and/or pro-tumorigenic actions. As expected, this “senescence-associated secretory phenotype (SASP)” accounts for most of the non-cell-autonomous effects of senescent cells, which can be beneficial or detrimental for tissue homeostasis, depending on the context. It is now evident that many features linked to cellular senescence, including the SASP, reflect complex changes in the activities of mTOR and other metabolic pathways. Indeed, the available evidence indicates that mTOR-dependent signaling is required for the maintenance or implementation of different aspects of cellular senescence. Thus, depending on the cell type and biological context, inhibiting mTOR in cells undergoing senescence can reverse senescence, induce quiescence or cell death, or exacerbate some features of senescent cells while inhibiting others. Interestingly, autophagy—a highly regulated catabolic process—is also commonly upregulated in senescent cells. As mTOR activation leads to repression of autophagy in non-senescent cells (mTOR as an upstream regulator of autophagy), the upregulation of autophagy observed in senescent cells must take place in an mTOR-independent manner. Notably, there is evidence that autophagy provides free amino acids that feed the mTOR complex 1 (mTORC1), which in turn is required to initiate the synthesis of SASP components. Therefore, mTOR activation can follow the induction of autophagy in senescent cells (mTOR as a downstream effector of autophagy). These functional connections suggest the existence of autophagy regulatory pathways in senescent cells that differ from those activated in non-senescence contexts. We envision that untangling these functional connections will be key for the generation of combinatorial anti-cancer therapies involving pro-senescence drugs, mTOR inhibitors, and/or autophagy inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22158149

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Research works printed but not linked: 128

  1. Tominaga, 2015, The emerging role of senescent cells in tissue homeostasis and pathophysiology, Pathobiol. Aging Age-Related Dis., 5, 27743, 10.3402/pba.v5.27743 · DOI · Paper page
  2. Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging, Proc. Natl. Acad. Sci. USA, 98, 12072, 10.1073/pnas.211053698 · DOI · Paper page
  3. Ghosh, 2016, The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging, J. Investig. Dermatol., 136, 2133, 10.1016/j.jid.2016.06.621 · DOI · Paper page
  4. Ruas, 2007, CDK4 and CDK6 Delay Senescence by Kinase-Dependent and p16INK4a-Independent Mechanisms, Mol. Cell. Biol., 27, 4273, 10.1128/MCB.02286-06 · DOI · Paper page
  5. Bollard, 2016, Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma, Gut, 66, 1286, 10.1136/gutjnl-2016-312268 · DOI · Paper page
  6. Asby, 2018, Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity, Cancer Manag. Res., 10, 3483, 10.2147/CMAR.S167095 · DOI
  7. Goel, 2018, CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest, Trends Cell Biol., 28, 911, 10.1016/j.tcb.2018.07.002 · DOI · Paper page
  8. Chen, 2007, DNA damage, cellular senescence and organismal ageing: Causal or correlative?, Nucleic Acids Res., 35, 7417, 10.1093/nar/gkm681 · DOI · Paper page
  9. Saleh, T., Bloukh, S., Carpenter, V.J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., and Gewirtz, D.A. (2020). Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy. Cancers, 12. · DOI · Paper page
  10. Regulski, 2017, Cellular Senescence: What, Why, and How, Wounds, 29, 168
  11. Carnero, 2015, Disruptive chemicals, senescence and immortality, Carcinog., 36, S19, 10.1093/carcin/bgv029 · DOI · Paper page
  12. Lipchick, 2017, The Immortal Senescence, Methods Mol. Biology, 1534, 1, 10.1007/978-1-4939-6670-7_1 · DOI
  13. Sikora, 2016, Morphological and Functional Characteristic of Senescent Cancer Cells, Curr. Drug Targets, 17, 377, 10.2174/1389450116666151019094724 · DOI · Paper page
  14. Kanherkar, 2016, Cellular Senescence as the Causal Nexus of Aging, Front. Genet., 7, 13
  15. Chatsirisupachai, 2019, A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence, Aging Cell, 18, e13041, 10.1111/acel.13041 · DOI · Paper page
  16. Rhinn, 2019, Cellular senescence in development, regeneration and disease, Development, 146, dev151837, 10.1242/dev.151837 · DOI · Paper page
  17. Ohtani, 2017, The role of SASP in tumor microenvironment, Clin. Calcium, 27, 835
  18. Kim, 2019, Cellular senescence in cancer, BMB Rep., 52, 42, 10.5483/BMBRep.2019.52.1.295 · DOI
  19. Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
  20. Nakao, 2020, Cellular Senescence Variation by Metabolic and Epigenomic Remodeling, Trends Cell Biol., 30, 919, 10.1016/j.tcb.2020.08.009 · DOI
  21. Sabbatinelli, 2019, Where Metabolism Meets Senescence: Focus on Endothelial Cells, Front. Physiol., 10, 1523, 10.3389/fphys.2019.01523 · DOI · Paper page
  22. Serrano, 2015, The InflammTORy Powers of Senescence, Trends Cell Biol., 25, 634, 10.1016/j.tcb.2015.09.011 · DOI
  23. Sarbassov, 2006, Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB, Mol. Cell, 22, 159, 10.1016/j.molcel.2006.03.029 · DOI · Paper page
  24. Yip, 2010, Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition, Mol. Cell, 38, 768, 10.1016/j.molcel.2010.05.017 · DOI · Paper page
  25. Su, 2017, mTORC1 senses stresses: Coupling stress to proteostasis, BioEssays, 39, 1600268, 10.1002/bies.201600268 · DOI
  26. Fu, W., and Hall, M.N. (2020). Regulation of mTORC2 Signaling. Genes, 11. · DOI · Paper page
  27. Schreiber, 2015, Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK 506-binding proteins, Aging Cell, 14, 265, 10.1111/acel.12313 · DOI · Paper page
  28. Betz, 2013, Where is mTOR and what is it doing there?, J. Cell Biol., 203, 563, 10.1083/jcb.201306041 · DOI · Paper page
  29. Puertollano, 2014, mTOR and lysosome regulation, F1000Prime Rep., 6, 52, 10.12703/P6-52 · DOI · Paper page
  30. Eltschinger, 2016, TOR Complexes and the Maintenance of Cellular Homeostasis, Trends Cell Biol., 26, 148, 10.1016/j.tcb.2015.10.003 · DOI · Paper page
  31. 2019, mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer, Front. Oncol., 9, 1373, 10.3389/fonc.2019.01373 · DOI · Paper page
  32. Rabanal-Ruiz, Y., and Korolchuk, V.I. (2018). mTORC1 and Nutrient Homeostasis: The Central Role of the Lysosome. Int. J. Mol. Sci., 19. · DOI · Paper page
  33. Wang, 2017, Activity-independent targeting of mTOR to lysosomes in primary osteoclasts, Sci. Rep., 7, 3005, 10.1038/s41598-017-03494-2 · DOI
  34. Caron, 2015, The Roles of mTOR Complexes in Lipid Metabolism, Annu. Rev. Nutr., 35, 321, 10.1146/annurev-nutr-071714-034355 · DOI · Paper page
  35. Lamming, 2013, A Central Role for mTOR in Lipid Homeostasis, Cell Metab., 18, 465, 10.1016/j.cmet.2013.08.002 · DOI · Paper page
  36. Chauvin, 2014, Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program, Oncogene, 33, 474, 10.1038/onc.2012.606 · DOI · Paper page
  37. Qin, 2016, 4E-BP1, a multifactor regulated multifunctional protein, Cell Cycle, 15, 781, 10.1080/15384101.2016.1151581 · DOI · Paper page
  38. Howell, 2013, A growing role for mTOR in promoting anabolic metabolism, Biochem. Soc. Trans., 41, 906, 10.1042/BST20130041 · DOI · Paper page
  39. Condon, 2019, Nutrient regulation of mTORC1 at a glance, J. Cell Sci., 132, jcs222570, 10.1242/jcs.222570 · DOI · Paper page
  40. Menon, 2008, Common corruption of the mTOR signaling network in human tumors, Oncogene, 27, S43, 10.1038/onc.2009.352 · DOI · Paper page
  41. Papadopoli, 2019, mTOR as a central regulator of lifespan and aging, F1000Research, 8, 998, 10.12688/f1000research.17196.1 · DOI · Paper page
  42. Kolesnichenko, 2012, Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence, Cell Cycle, 11, 2391, 10.4161/cc.20683 · DOI · Paper page
  43. Pospelova, 2013, Rapamycin induces pluripotent genes associated with avoidance of replicative senescence, Cell Cycle, 12, 3841, 10.4161/cc.27396 · DOI
  44. Gillespie, 2015, Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production, Nucleus, 6, 490, 10.1080/19491034.2015.1128610 · DOI
  45. Leontieva, 2015, Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program), Oncotarget, 6, 23238, 10.18632/oncotarget.4836 · DOI · Paper page
  46. Chen, 2010, Altered mTOR Signaling in Senescent Retinal Pigment Epithelium, Investig. Opthalmology Vis. Sci., 51, 5314, 10.1167/iovs.10-5280 · DOI · Paper page
  47. Terzi, 2016, The cell fate: Senescence or quiescence, Mol. Biol. Rep., 43, 1213, 10.1007/s11033-016-4065-0 · DOI · Paper page
  48. Serrano, 2010, Shifting senescence into quiescence by turning up p53, Cell Cycle, 9, 4256, 10.4161/cc.9.21.13785 · DOI · Paper page
  49. Leontieva, 2010, Weak p53 permits senescence during cell cycle arrest, Cell Cycle, 9, 4323, 10.4161/cc.9.21.13584 · DOI · Paper page
  50. Liu, 2020, Functional crosstalk between mTORC1/p70S6K pathway and heterochromatin organization in stress-induced senescence of MSCs, Stem Cell Res. Ther., 11, 279, 10.1186/s13287-020-01798-1 · DOI
  51. Khor, 2018, Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107, Int. J. Biochem. Cell Biol., 101, 64, 10.1016/j.biocel.2018.05.016 · DOI
  52. Khor, 2020, The roles of MTOR and miRNAs in endothelial cell senescence, Biogerontology, 21, 517, 10.1007/s10522-020-09876-w · DOI
  53. Schaub, 2019, mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells, Sci. Rep., 9, 20071, 10.1038/s41598-019-56237-w · DOI
  54. Martin, 2015, Brief Report: The Differential Roles of mTORC1 and mTORC2 in Mesenchymal Stem Cell Differentiation, Stem Cells, 33, 1359, 10.1002/stem.1931 · DOI
  55. Zheng, 2017, mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells, Int. J. Dev. Biol., 61, 65, 10.1387/ijdb.160207dz · doi:10.1387/ijdb.160207dz
  56. Piegari, 2013, Doxorubicin induces senescence and impairs function of human cardiac progenitor cells, Basic Res. Cardiol., 108, 334, 10.1007/s00395-013-0334-4 · DOI · Paper page
  57. Cesselli, 2017, Cardiac Cell Senescence and Redox Signaling, Front. Cardiovasc. Med., 4, 38, 10.3389/fcvm.2017.00038 · DOI
  58. Manzella, 2018, Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy, Aging Cell, 17, e12811, 10.1111/acel.12811 · DOI · Paper page
  59. Occhipinti, 2020, Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications, Front. Genet., 11, 349, 10.3389/fgene.2020.00349 · DOI
  60. Michaloglou, 2018, Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer, Mol. Cancer Ther., 17, 908, 10.1158/1535-7163.MCT-17-0537 · DOI · Paper page
  61. Wong, 2019, PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer, Endocr.-Relat. Cancer, 26, 425, 10.1530/ERC-19-0011 · DOI
  62. Song, 2018, Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma, Clin. Cancer Res., 25, 403, 10.1158/1078-0432.CCR-18-0284 · DOI
  63. Yamamoto, 2019, Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer, Breast Cancer Res. Treat., 174, 615, 10.1007/s10549-018-05104-9 · DOI
  64. Chen, 2019, Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway, Med. Sci. Monit., 25, 77, 10.12659/MSM.912929 · doi:10.12659/msm.912929
  65. Cretella, 2018, The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells, J. Exp. Clin. Cancer Res., 37, 72, 10.1186/s13046-018-0741-3 · DOI · Paper page
  66. Knudsen, 2019, Cell cycle plasticity driven by MTOR signaling: Integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer, Oncogene, 38, 3355, 10.1038/s41388-018-0650-0 · DOI
  67. Kumarasamy, 2020, Chemotherapy impacts on the cellular response to CDK4/6 inhibition: Distinct mechanisms of interaction and efficacy in models of pancreatic cancer, Oncogene, 39, 1831, 10.1038/s41388-019-1102-1 · DOI
  68. Bonelli, 2017, Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells, Neoplasia, 19, 637, 10.1016/j.neo.2017.05.003 · DOI
  69. Yuxiang, 2019, Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer, Cancer Biol. Med., 16, 66, 10.20892/j.issn.2095-3941.2018.0361 · DOI
  70. McDermott, 2020, Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer, Breast Cancer Res., 22, 89, 10.1186/s13058-020-01320-8 · DOI
  71. Figlia, 2020, Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1, Cell Rep., 31, 107504, 10.1016/j.celrep.2020.03.068 · DOI
  72. Kimmelman, 2011, The dynamic nature of autophagy in cancer, Genes Dev., 25, 1999, 10.1101/gad.17558811 · DOI · Paper page
  73. Yu, 2018, Autophagy pathway: Cellular and molecular mechanisms, Autophagy, 14, 207, 10.1080/15548627.2017.1378838 · DOI · Paper page
  74. Chen, 2010, Autophagy and tumorigenesis, FEBS Lett., 584, 1427, 10.1016/j.febslet.2009.12.034 · DOI · Paper page
  75. Guo, 2016, Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells, Genes Dev., 30, 1704, 10.1101/gad.283416.116 · DOI · Paper page
  76. Mizushima, 2011, Autophagy: Renovation of Cells and Tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026 · DOI · Paper page
  77. White, 2015, Autophagy, Metabolism, and Cancer, Clin. Cancer Res., 21, 5037, 10.1158/1078-0432.CCR-15-0490 · DOI · Paper page
  78. Li, 2020, Autophagy and autophagy-related proteins in cancer, Mol. Cancer, 19, 12, 10.1186/s12943-020-1138-4 · DOI · Paper page
  79. Li, 2020, Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation, Nat. Commun., 11, 3806, 10.1038/s41467-020-17395-y · DOI · Paper page
  80. Bao, 2020, Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-β/Smad3 signaling in melanoma cells, Cell Death Dis., 11, 223, 10.1038/s41419-020-2419-y · DOI
  81. White, 2019, Role of tumor and host autophagy in cancer metabolism, Genes Dev., 33, 610, 10.1101/gad.325514.119 · DOI · Paper page
  82. White, 2021, Autophagy Regulates Stress Responses, Metabolism, and Anticancer Immunity, Trends Cancer, 7, 778, 10.1016/j.trecan.2021.05.003 · DOI
  83. Abada, 2014, Getting ready for building: Signaling and autophagosome biogenesis, EMBO Rep., 15, 839, 10.15252/embr.201439076 · DOI · Paper page
  84. Wen, 2016, An overview of macroautophagy in yeast, J. Mol. Biol., 428, 1681, 10.1016/j.jmb.2016.02.021 · DOI · Paper page
  85. Saftig, 2016, Turn up the lysosome, Nat. Cell Biol., 18, 1025, 10.1038/ncb3409 · DOI
  86. Kraft, 2012, Mechanisms and regulation of autophagosome formation, Curr. Opin. Cell Biol., 24, 496, 10.1016/j.ceb.2012.05.001 · DOI
  87. Kawabata, 2020, Autophagosome biogenesis and human health, Cell Discov., 6, 33, 10.1038/s41421-020-0166-y · DOI
  88. Yang, 2009, An Overview of the Molecular Mechanism of Autophagy, Curr. Top. Microbiol. Immunol., 335, 1
  89. Schmeisser, 2019, Pleiotropic Effects of mTOR and Autophagy during Development and Aging, Front. Cell Dev. Biol., 7, 192, 10.3389/fcell.2019.00192 · DOI · Paper page
  90. Kim, 2013, Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy, Cell, 152, 290, 10.1016/j.cell.2012.12.016 · DOI · Paper page
  91. Nazio, 2013, mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6, Nat. Cell Biol., 15, 406, 10.1038/ncb2708 · DOI · Paper page
  92. Yuan, 2013, Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy, Autophagy, 9, 1983, 10.4161/auto.26058 · DOI · Paper page
  93. Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J., 31, 1095, 10.1038/emboj.2012.32 · DOI · Paper page
  94. Kim, 2011, Regulation of the autophagy initiating kinase ULK1 by nutrients: Roles of mTORC1 and AMPK, Cell Cycle, 10, 1337, 10.4161/cc.10.9.15291 · DOI
  95. Ganley, 2009, ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy, J. Biol. Chem., 284, 12297, 10.1074/jbc.M900573200 · DOI · Paper page
  96. Martina, 2012, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB, Autophagy, 8, 903, 10.4161/auto.19653 · DOI · Paper page
  97. Petit, 2012, The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis, Sci. Signal., 5, ra42
  98. Lim, 2016, The lysosome as a command-and-control center for cellular metabolism, J. Cell Biol., 214, 653, 10.1083/jcb.201607005 · DOI · Paper page
  99. Xu, 2020, Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways, Ann. N. Y. Acad. Sci., 1467, 3, 10.1111/nyas.14305 · DOI · Paper page
  100. Wyant, 2017, Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes, Science, 358, 807, 10.1126/science.aan6298 · DOI · Paper page
  101. Shen, J., Wu, G., and Guo, S. (2021). Amino Acids in Autophagy: Regulation and Function. Amino Acids in Nutrition and Health, Springer. · DOI
  102. Angarola, 2020, Coordination of Rheb lysosomal membrane interactions with mTORC1 activation, F1000Research, 9, 450, 10.12688/f1000research.22367.1 · DOI
  103. Deng, 2019, Ubiquitination of Rheb governs growth factor-induced mTORC1 activation, Cell Res., 29, 136, 10.1038/s41422-018-0120-9 · DOI
  104. Abraham, 2010, Lysosomal Rag-ulation of mTOR Complex 1 Activity, Cell Metab., 11, 341, 10.1016/j.cmet.2010.04.010 · DOI
  105. Mu, 2017, Structural insight into the Ragulator complex which anchors mTORC1 to the lysosomal membrane, Cell Discov., 3, 17049, 10.1038/celldisc.2017.49 · DOI · Paper page
  106. Brady, 2016, Rags to riches: Amino acid sensing by the Rag GTPases in health and disease, Small GTPases, 7, 197, 10.1080/21541248.2016.1218990 · DOI
  107. Kwon, 2017, Autophagy Is Pro-Senescence When Seen in Close-Up, but Anti-Senescence in Long-Shot, Mol. Cells, 40, 607, 10.14348/molcells.2017.0151 · DOI · Paper page
  108. Slobodnyuk, 2019, Autophagy-induced senescence is regulated by p38α signaling, Cell Death Dis., 10, 376, 10.1038/s41419-019-1607-0 · DOI · Paper page
  109. Bernard, 2020, Autophagy drives fibroblast senescence through MTORC2 regulation, Autophagy, 16, 2004, 10.1080/15548627.2020.1713640 · DOI · Paper page
  110. Rastaldo, 2020, Dual Role of Autophagy in Regulation of Mesenchymal Stem Cell Senescence, Front. Cell Dev. Biol., 8, 276, 10.3389/fcell.2020.00276 · DOI
  111. Carroll, 2017, Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing, J. Cell Biol., 216, 1949, 10.1083/jcb.201610113 · DOI · Paper page
  112. Carroll, 2018, Nutrient sensing, growth and senescence, FEBS J., 285, 1948, 10.1111/febs.14400 · DOI · Paper page
  113. Liu, 2019, Cellular Senescence-Inducing Small Molecules for Cancer Treatment, Curr. Cancer Drug Targets, 19, 109, 10.2174/1568009618666180530092825 · DOI
  114. Bojko, A., Czarnecka-Herok, J., Charzynska, A., Dabrowski, M., and Sikora, E. (2019). Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents. Cells, 8. · DOI · Paper page
  115. Dunlop, 2014, mTOR and autophagy: A dynamic relationship governed by nutrients and energy, Semin. Cell Dev. Biol., 36, 121, 10.1016/j.semcdb.2014.08.006 · DOI · Paper page
  116. Carroll, 2017, The lysosome: A crucial hub for AMPK and mTORC1 signalling, Biochem. J., 474, 1453, 10.1042/BCJ20160780 · DOI · Paper page
  117. Dossou, A.S., and Basu, A. (2019). The Emerging Roles of mTORC1 in Macromanaging Autophagy. Cancers, 11. · DOI · Paper page
  118. Payea, 2020, Translational Control during Cellular Senescence, Mol. Cell. Biol., 41, e00512-20, 10.1128/MCB.00512-20 · DOI · Paper page
  119. Brown, 2012, Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium, Cancer Res., 72, 6477, 10.1158/0008-5472.CAN-11-4139 · DOI · Paper page
  120. Valenzuela, 2017, Palbociclib-induced autophagy and senescence in gastric cancer cells, Exp. Cell Res., 360, 390, 10.1016/j.yexcr.2017.09.031 · DOI · Paper page
  121. Okada, 2017, Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines, Oncol. Rep., 38, 31, 10.3892/or.2017.5684 · DOI
  122. Vijayaraghavan, 2017, CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers, Nat. Commun., 8, 15916, 10.1038/ncomms15916 · DOI · Paper page
  123. Chittaranjan, 2014, Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer, Clin. Cancer Res., 20, 3159, 10.1158/1078-0432.CCR-13-2060 · DOI · Paper page
  124. Lefort, 2014, Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers, Autophagy, 10, 2122, 10.4161/15548627.2014.981788 · DOI · Paper page
  125. Gewirtz, 2013, Autophagy and senescence in cancer therapy, J. Cell. Physiol., 229, 6
  126. Patel, 2020, The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation, Radiat. Res., 194, 103, 10.1667/RADE-20-00009 · DOI
  127. Goehe, 2012, The Autophagy-Senescence Connection in Chemotherapy: Must Tumor Cells (Self) Eat Before They Sleep?, J. Pharmacol. Exp. Ther., 343, 763, 10.1124/jpet.112.197590 · DOI
  128. Pawlowska, E., Szczepanska, J., Szatkowska, M., and Blasiak, J. (2018). An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme—Role in Pathogenesis and Therapeutic Perspective. Int. J. Mol. Sci., 19. · DOI

Cited by

Metadata

Authors
Cayo, A., Segovia, R., Venturini, W., Moore-Carrasco, R., Valenzuela, C., & Brown, N.
Affiliations
  • Center for Medical Research, University of Talca School of Medicine, Talca 346000, Chile
  • Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, University of Talca, Talca 346000, Chile
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-07-29
Volume
22
Issue
15
Pages
8149
ISSN
1422-0067
Cited by
93
References
80
Language
en
Funders
  • Fondo Nacional de Desarrollo Científico y Tecnológico (11201182)
  • Programa de Investigación Asociativa en Cáncer Gástrico (PIA-CG, RU2107)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.